CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 38 enrolled
Drug / intervention
Lokomat +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00607126
NCT00607126Phase 2Completed
CompareCT.gov

Robotic Locomotor Training in Persons With Multiple Sclerosis

University of California, Los Angeles·interventional·Posted Feb 5, 2008·Updated Aug 15, 2016

In Brief

A Phase 2 clinical trial evaluating Lokomat and resistive training for Multiple Sclerosis. Completed, enrolled 38 participants across 1 site.

Detailed Summary

Locomotor training is a new exercise modality that emphasizes task specificity to promote learning and neural plasticity. It has been reported to improve walking in patients with stroke, spinal cord injury and cerebral palsy. In this study, 40 patients with impaired ambulation due to Multiple Sclerosis will be randomized to receive 36 sessions of either locomotor training or an standard resistive exercise intervention.The locomotor training will be accomplished via a robotic device, the Lokomat, which will move the patient's legs on a treadmill while they are suspended in a harness.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMultiple Sclerosis
CountriesUnited States
CollaboratorsNational Multiple Sclerosis Society

Timeline

Phase 2CompletedFinished
2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedFeb 5, 2008
Enrollment StartJul 1, 2006
Primary CompletionAug 1, 2009
TodayJul 2, 2026
Enrollment to primary: 3.1 yearsPosted 18.4 years ago

Interventions

Lokomatdevice

locomotor training using body weight support on a treadmill

resistive trainingprocedure

resistive training using theraband and/or weights